UVNAES-MOBERG KERSTIN has a total of 11 patent applications. Its first patent ever was published in 1998. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and basic materials chemistry are MODIGENE INC, AVAXIA BIOLOGICS INC and PBL BIOMEDICAL LAB.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Basic materials chemistry | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Preservation of human bodies | |
#5 | Specific use of cosmetics |
# | Name | Total Patents |
---|---|---|
#1 | Uvnaes-Moberg Kerstin | 11 |
#2 | Lundeberg Thomas | 9 |
#3 | Lundegaardh Bengt | 2 |
#4 | Petersson Maria | 2 |
Publication | Filing date | Title |
---|---|---|
WO03017922A2 | Use of substances with oxytocin activity for the preparation of a pharmaceutical composition against inflammation | |
WO02102832A1 | Use of fragments of oxytocin for the preparation of a pharmaceutical composition in order to create eustasis | |
WO02102160A1 | Use of a substance with oxytocin activity in order to stimulate plant growth | |
US7405200B2 | Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis |